- Home
- AMPG vs ANL Comparison
AMPG vs ANL Comparison
Compare AMPG & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- ANL
- Stock Information
- Founded
- AMPG 2002
- ANL 2004
- Country
- AMPG United States
- ANL Cayman Islands
- Employees
- AMPG N/A
- ANL N/A
- Industry
- AMPG Telecommunications Equipment
- ANL
- Sector
- AMPG Telecommunications
- ANL
- Exchange
- AMPG Nasdaq
- ANL Nasdaq
- Market Cap
- AMPG 46.7M
- ANL 56.0M
- IPO Year
- AMPG N/A
- ANL 2023
- Fundamental
- Price
- AMPG $3.07
- ANL $1.44
- Analyst Decision
- AMPG Strong Buy
- ANL Hold
- Analyst Count
- AMPG 1
- ANL 1
- Target Price
- AMPG $5.00
- ANL N/A
- AVG Volume (30 Days)
- AMPG 483.5K
- ANL 6.1K
- Earning Date
- AMPG 08-13-2025
- ANL 08-08-2025
- Dividend Yield
- AMPG N/A
- ANL N/A
- EPS Growth
- AMPG N/A
- ANL N/A
- EPS
- AMPG N/A
- ANL N/A
- Revenue
- AMPG $10,814,140.00
- ANL N/A
- Revenue This Year
- AMPG $114.55
- ANL N/A
- Revenue Next Year
- AMPG $50.00
- ANL N/A
- P/E Ratio
- AMPG N/A
- ANL N/A
- Revenue Growth
- AMPG N/A
- ANL N/A
- 52 Week Low
- AMPG $0.64
- ANL $1.10
- 52 Week High
- AMPG $6.43
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- AMPG 68.00
- ANL 42.36
- Support Level
- AMPG $2.61
- ANL $1.48
- Resistance Level
- AMPG $3.20
- ANL $1.55
- Average True Range (ATR)
- AMPG 0.22
- ANL 0.05
- MACD
- AMPG 0.07
- ANL 0.00
- Stochastic Oscillator
- AMPG 88.50
- ANL 5.00
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.